GlassScriptPhysician profile
Brano Djenic
NPI 1649537556
$5,659.72
in general payments reported to CMS, 2019-2025
19 companies · $350 in 2025
The $350 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,840 · 2020: $47.55 · 2021: $116 · 2022: $259 · 2023: $18.50 · 2024: $29.36 · 2025: $350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $397.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,630.96 | 2019-2025 | |
| Dilon Technologies, INC. | $145.21 | 2025 | Hemoblast Bellows |
| Tela Bio, INC. | $137.67 | 2019-2022 | |
| Janssen Biotech, INC. | $124.99 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $115.79 | 2022 | |
| Medical Device Business Services, INC. | $112.12 | 2019 | |
| Trevena, INC. | $99.99 | 2021 | |
| Ethicon US, LLC | $63.67 | 2025 | Harmonic |
| Amgen INC. | $34.25 | 2020 | |
| Medtronic, INC. | $29.36 | 2024 | Eea |
| Pharmacosmos Therapeutics INC. | $28.27 | 2025 | Monoferric |
| Mimedx Group, INC. | $22.35 | 2025 | |
| Stemline Therapeutics INC. | $20.22 | 2022 | |
| Cook Biotech Incorporated | $18.50 | 2023 | Biodesign |
| Kerecis Limited | $17.76 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $16.95 | 2019 | |
| Biocompatibles, INC. | $15.14 | 2019 | |
| Exelixis INC. | $13.30 | 2020 | |
| Genentech USA, INC. | $13.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brano Djenic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.